Stable FTO promotes BLCA cell proliferation and migration in vitro and tumor development in vivo by decreasing the m6A methylation of pyrrolidine 5‐carboxylate reductase 1 (PYCR1) and lengthening the mRNA half‐life of PYCR1 [85]. Here, PYCR1 is linked to bladder transitional cell carcinoma.